Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Cited by (1,001)

Items 401–500 of 1,001

1. Update on Infections in Primary Antibody Deficiencies
   Yeşim Yılmaz Demirdağ, Sudhir Gupta · 2021 · Frontiers in Immunology
2. Immunotherapy use outside clinical trial populations: never say never?
   Karolina Rzeniewicz, James Larkin, Alexander Maxwell Menzies, Samra Turajlic · 2021 · Annals of Oncology
3. Peculiarities of the T Cell Immune Response in COVID-19
   Dmitry Anatolievich Kudlay, И.А. Кофиади, Musa Rakhimovich Khaitov · 2022 · Vaccines
4. SARS-CoV-2 vaccination induces immunological memory able to cross-recognize variants from Alpha to Omicron
   Alison Tarke, Camila H. Coelho, Zeli Zhang, Jennifer M. Dan, Esther Dawen Yu, Nils Methot, Nathaniel I. Bloom, Benjamin Goodwin, Elizabeth Jane Phillips, Simon Alexander Mallal et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
5. Immunology of COVID ‐19
   Harald Brüssow · 2020 · Environmental Microbiology
6. The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity
   Leiqiong Gao, Jing Zhou, Sen Yang, Lisha Wang, Xiangyu Chen, Yang Yang, Ren Li, Zhiwei Pan, Ye Zhao, Zhirong Li et al. · 2021 · Signal Transduction and Targeted Therapy
7. Correlates of protection against symptomatic SARS-CoV-2 in vaccinated children
   Youjia Zhong, Alicia Yi Hui Kang, Carina Jing Xuan Tay, Hui’ En Li, Nurul Elyana, Chee Wah Tan, Wee Chee Yap, Joey Ming Er Lim, Nina Le Bert, Kuan Rong Chan et al. · 2024 · Nature Medicine
8. Lessons in antiviral immunity
   Jennifer L. Hope, Linda M. Bradley · 2021 · Science
9. Vaccination and multiple sclerosis in the era of the COVID-19 pandemic
   Tobias Monschein, Hans‐Peter Hartung, Tobias Zrzavy, Michael Harry Barnett, Nina Boxberger, Thomas Berger, Jeremy Chataway, Amit Bar‐Or, Paulus Stefan Rommer, Uwe Klaus Zettl · 2021 · Journal of Neurology Neurosurgery & Psychiatry
10. Projecting the SARS-CoV-2 transition from pandemicity to endemicity: Epidemiological and immunological considerations
    Lily Cohen, David J. Spiro, Cecile G. Viboud · 2022 · PLoS Pathogens
11. A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responses
    Alexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, Shang Yu Gong, Romain Gasser, Guillaume Beaudoin-Bussières, Nathalie Brassard, Annemarie Laumaea, Dani Vézina, Jérémie Prévost et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
12. Secretory IgA and T cells targeting SARS-CoV-2 spike protein are transferred to the breastmilk upon mRNA vaccination
    Juliana Gonçalves, A. Margarida Juliano, Nádia Charepe, Marta Alenquer, Diogo Athayde, Filipe Ferreira, Margarida Archer, Maria João Amorim, Fátima Serrano, Helena Soares · 2021 · Cell Reports Medicine
13. Efficacy and Safety of Third Dose of the COVID-19 Vaccine among Solid Organ Transplant Recipients: A Systemic Review and Meta-Analysis
    Orly Efros, Roi Anteby, Mirit Halfon, Eshcar Meisel, Eyal Klang, Shelly Soffer · 2022 · Vaccines
14. Heterogenous CD8+ T Cell Maturation and ‘Polarization’ in Acute and Convalescent COVID-19 Patients
    Igor Vladimirovich Kudryavtsev, Natalia A. Arsentieva, Zoia R. Korobova, Dmitry Isakov, Artem Rubinstein, Oleg K. Batsunov, I. V. Khamitova, Raisa N. Kuznetsova, Савин Тихон Валерьевич, Tatiana Akisheva et al. · 2022 · Viruses
15. Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection
    Titus Abiola Olukitibi, Zhujun Ao, Bryce M. Warner, Rodrigo Unat, Darwyn Kobasa, Xiaojian Yao · 2023 · Vaccines
16. Nucleocapsid-specific T cell responses associate with control of SARS-CoV-2 in the upper airways before seroconversion
    Tabea M. Eser, Olga Baranov, Manuel Huth, Mohammed I. M. Ahmed, Flora Deák, Kathrin Held, Luming Lin, Kami Pekayvaz, Alexander Leunig, Leo Nicolai et al. · 2023 · Nature Communications
17. SARS-CoV-2 variants: biology, pathogenicity, immunity and control
    Ryuta Uraki, Bette Korber, Michael Diamond, Yoshihiro Kawaoka · 2025 · Nature Reviews Microbiology
18. B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications
    Marco Iannetta, Doriana Landi, Gaia Cola, Laura Campogiani, Vincenzo Malagnino, Elisabetta Teti, Luigi Coppola, Andrea Di Lorenzo, Daniela Fraboni, Francesco Buccisano et al. · 2022 · Frontiers in Immunology
19. Molecular and cellular immune features of aged patients with severe COVID-19 pneumonia
    Domenico Lo Tartaro, Anita Neroni, Annamaria Paolini, Rebecca Borella, Marco Mattioli, Lucia Fidanza, Andrew A. Quong, Carlene Petes, Génève Awong, Samuel Douglas et al. · 2022 · Communications Biology
20. SARS-CoV-2-specific CD4+ and CD8+ T cell responses can originate from cross-reactive CMV-specific T cells
    Cilia R. Pothast, Romy C. Dijkland, Melissa Thaler, Renate S. Hagedoorn, Michel G.D. Kester, Anne K. Wouters, Pieter Sicco Hiemstra, Martijn J. van Hemert, Stéphanie Gras, J.H. Frederik Falkenburg et al. · 2022 · eLife
21. How could we forget immunometabolism in SARS-CoV2 infection or COVID-19?
    Vijay Kumar · 2020 · International Reviews of Immunology
22. Insights into neutralizing antibody responses in individuals exposed to SARS-CoV-2 in Chile
    C. Beltrán-Pavez, S. Riquelme-Barrios, A. Oyarzún-Arrau, A. Gaete-Argel, R. González-Stegmaier, Karina Cereceda-Solis, A. Aguirre, D. Travisany, R. Palma-Véjares, Gonzalo P. Barriga et al. · 2021 · Science Advances
23. COVID-19 Vaccines: Current and Future Perspectives
    Luca Soraci, Fabrizia Lattanzio, Giulia Soraci, Maria Elsa Gambuzza, Claudio Pulvirenti, Annalisa Cozza, Andrea Corsonello, Filippo Luciani, Giovanni Rezza · 2022 · Vaccines
24. COVID-19 vaccines: Immune correlates and clinical outcomes
    Shant H. Mahrokhian, Lisa H. Tostanoski, Samuel J. Vidal, Dan H. Barouch · 2024 · Human Vaccines & Immunotherapeutics
25. The impact of immuno-aging on SARS-CoV-2 vaccine development
    Jennifer R Connors, Matthew R. Bell, Jennifer Marcy, Michele A. Kutzler, Elias K. Haddad · 2021 · GeroScience
26. Antigen‐dependent multistep differentiation of T follicular helper cells and its role in SARS‐CoV‐2 infection and vaccination
    Dirk Baumjohann, Nicolas Fazilleau · 2021 · European Journal of Immunology
27. A Single-Cycle Influenza A Virus-Based SARS-CoV-2 Vaccine Elicits Potent Immune Responses in a Mouse Model
    Surapong Koonpaew, Challika Kaewborisuth, Kanjana Srisutthisamphan, Asawin Wanitchang, Theeradej Thaweerattanasinp, Janya Saenboonrueng, Sukontip Poonsuk, Juggragarn Jengarn, Ratchanont Viriyakitkosol, Jarin Kramyu et al. · 2021 · Vaccines
28. Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection
    Michael J. Christie, Aaron Trent Irving, Samuel C. Forster, Benjamin J. Marsland, Philip M. Hansbro, Paul J. Hertzog, Claudia A. Nold‐Petry, Marcel F. Nold · 2021 · Science Immunology
29. Screening HLA-A-restricted T cell epitopes of SARS-CoV-2 and the induction of CD8+ T cell responses in HLA-A transgenic mice
    Xiaoxiao Jin, Yan Ding, Shihui Sun, Xinyi Wang, Zining Zhou, Xiaotao Kelvin Liu, Miaomiao Li, Xian Chen, Anran Shen, Yandan Wu et al. · 2021 · Cellular and Molecular Immunology
30. What level of neutralising antibody protects from COVID-19?
    Khoury, David S, Cromer, Deborah, Reynaldi, Arnold, Schlub, Timothy E, Wheatley, Adam K, Juno, Jennifer A, Subbarao, Kanta, Kent, Stephen J, Triccas, James A, Davenport, Miles P · 2021
31. Immunogenetic Association Underlying Severe COVID-19
    Kendall McCoy, Autumn Peterson, Yun Tian, Yongming Sang · 2020 · Vaccines
32. The relationship between hematocrit and serum albumin levels difference and mortality in elderly sepsis patients in intensive care units—a retrospective study based on two large database
    Zichen Wang, Luming Zhang, Shaojin Li, Fengshuo Xu, Didi Han, Hao Wang, Tao Huang, Haiyan Yin, Jun Lyu · 2022 · BMC Infectious Diseases
33. Correlates of protection for booster doses of the SARS-CoV-2 vaccine BNT162b2
    Tomer Hertz, Shlomia Levy, Daniel A. Ostrovsky, Hanna Oppenheimer, Shosh Zismanov, Alona Kuzmina, Lilach M. Friedman, Sanja Trifkovic, David C. Brice, Lin Chun-Yang et al. · 2023 · Nature Communications
34. Ferroptosis and pyroptosis signatures in critical COVID-19 patients
    Cédric Peleman, Samya Van Coillie, Symen Ligthart, Sze Men Choi, Jan J. De Waele, Pieter O Depuydt, Dominique Benoît, Hannah Schaubroeck, Sven Francque, Karolien Dams et al. · 2023 · Cell Death and Differentiation
35. SARS-CoV-2 breakthrough infections enhance T cell response magnitude, breadth, and epitope repertoire
    Alison Tarke, Parham Ramezani-Rad, Tertuliano Alves Pereira Neto, Yeji Lee, Vanessa Silva‐Moraes, Benjamin Goodwin, Nathaniel I. Bloom, Leila Siddiqui, Liliana Avalos, April Frazier et al. · 2024 · Cell Reports Medicine
36. Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients
    A. Marcos, Magdalena Salcedo, Roberto Alonso, Manuel Rodríguez‐Perálvarez, María Olmedo, Javier Graus Morales, Valentín Cuervas‐Mons, Alba Cachero, Carmelo Loinaz, Mercedes Iñarrairaegui et al. · 2021 · American Journal of Transplantation
37. Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through ‘reverse phenotyping’
    David S. Fischer, Meshal Ansari, Karolin I. Wagner, Sebastian Jarosch, Yiqi Huang, Christoph H. Mayr, Maximilian Strunz, Niklas Jonathan Lang, Elvira D’Ippolito, Monika Hammel et al. · 2021 · Nature Communications
38. Accuracy and real life performance of a novel interferon-γ release assay for the detection of SARS-CoV2 specific T cell response
    Daniela Huzly, Marcus Panning, Franziska Smely, Martin Enders, Johanna Komp, Valeria Falcone, Daniel Steinmann · 2022 · Journal of Clinical Virology
39. SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations
    Elizabeth M. Anderson, Shuk Hang Li, Moses Awofolaju, Theresa Eilola, Eileen C. Goodwin, Marcus J. Bolton, Sigrid Gouma, Tomaz B. Manzoni, Philip D. Hicks, Rishi R. Goel et al. · 2022 · Cell Reports
40. Targets and cross-reactivity of human T cell recognition of common cold coronaviruses
    Alison Tarke, Yun Zhang, Nils Methot, Tara M. Narowski, Elizabeth Jane Phillips, Simon Alexander Mallal, April Frazier, Gilberto Filaci, Daniela Weiskopf, Jennifer M. Dan et al. · 2023 · Cell Reports Medicine
41. Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses
    Patricia Almendro-Vázquez, Marta Chivite‐Lacaba, Alberto Utrero‐Rico, Cecilia González‐Cuadrado, Rocío Laguna‐Goya, Miguel Moreno-Batanero, Laura Sánchez-Paz, Joanna Luczkowiak, Nuria Labiod, María Dolores Folgueira et al. · 2022 · Frontiers in Immunology
42. New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic
    Jonatan J. Carvajal, Valeria García-Castillo, Shelsy V. Cuellar, Claudia P. Campillay-Véliz, Camila Salazar‐Ardiles, Andrea M. Avellaneda, Christian A. Muñoz, Angello R Retamal-Díaz, Susan M. Bueno, Pablo A. González et al. · 2024 · Frontiers in Immunology
43. Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients
    Li-Guo Zhu, Xin Xu, Bao-Li Zhu, Xi-Ling Guo, Ke Xu, Ci Song, Jian-Guang Fu, Hui-Yan Yu, Xiaoxiao Kong, Jiefu Peng et al. · 2021 · Microbiology spectrum
44. Human nasal wash RNA-Seq reveals distinct cell-specific innate immune responses in influenza versus SARS-CoV-2
    Kevin MingJie Gao, Alan G. Derr, Zhiru Guo, Kerstin Nündel, Ann Marshak‐Rothstein, Robert W. Finberg, Jennifer P Wang · 2021 · JCI Insight
45. T follicular helper cells in the humoral immune response to SARS-CoV-2 infection and vaccination
    Marios Koutsakos, Wen Shi Lee, Adam K Wheatley, Stephen J Kent, Jennifer A. Juno · 2021 · Journal of Leukocyte Biology
46. Association between inflammatory cytokines and anti-SARS-CoV-2 antibodies in hospitalized patients with COVID-19
    Xixi Jing, Min Xu, Deye Song, Tingting Yue, Yali Wang, Pan Zhang, Yanjun Zhong, Min Zhang, Tommy Tsan‐Yuk Lam, Nuno Rodrigues Faria et al. · 2022 · Immunity & Ageing
47. Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial
    Zoltán Bánki, José Mateus, Annika Rössler, Helena Schäfer, David Bante, Lydia Riepler, Alba Grifoni, Alessandro Sette, Viviana R. Simon, Barbara Falkensammer et al. · 2022 · EBioMedicine
48. Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity
    Jonah Lin, Ryan Law, Chapin S. Korosec, Christine Yang Zhou, Wan Hon Koh, Mohammad Sajjad Ghaemi, Philip Samaan, Hsu Kiang Ooi, Vitaliy A. Matveev, FengYun Yue et al. · 2022 · Journal of Virology
49. Protective Immunity after Natural Infection with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) – Kentucky, USA, 2020
    Kevin B. Spicer, Connor Glick, Alyson M. Cavanaugh, Douglas A. Thoroughman · 2021 · International Journal of Infectious Diseases
50. Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences
    Alessandra Aiello, Saeid Najafi Fard, Delia Goletti · 2023 · Frontiers in Immunology
51. Regulatory T Cells as Predictors of Clinical Course in Hospitalised COVID-19 Patients
    Sara Caldrer, Cristina Mazzi, Milena Bernardi, Marco Giuseppe Prato, Niccolò Ronzoni, Paola Rodari, Andrea Angheben, Chiara Piubelli, Natalia Tiberti · 2021 · Frontiers in Immunology
52. Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review
    Areez Shafqat, Shameel Shafqat, Sulaiman Alsalameh, Junaid Kashir, Khaled Manae AlKattan, Ahmed Yaqinuddin · 2022 · Frontiers in Immunology
53. Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues
    Christine E. Nelson, S. Namasivayam, Taylor W. Foreman, Keith D. Kauffman, Shunsuke Sakai, Danielle E. Dorosky, N. Lora, Kelsie Brooks, E. L. Potter, N. Garza et al. · 2022 · bioRxiv
54. TNF-α+ CD4+ T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodies
    Kattria van der Ploeg, Adam S. Kirosingh, Diego AM Mori, Saborni Chakraborty, Zicheng Hu, Benjamín L. Sievers, Karen Blake Jacobson, Hector Fabio Bonilla, Julie Parsonnet, Jason Randolph Andrews et al. · 2022 · Cell Reports Medicine
55. Recovering or Persisting: The Immunopathological Features of SARS-CoV-2 Infection in Children
    Danilo Buonsenso, Piero Valentini, Cristina De Rose, Maria Tredicine, Maria del Carmen Pereyra Boza, Chiara Camponeschi, Rosa Morello, Giuseppe Zampino, Anna E. S. Brooks, Mario Rende et al. · 2022 · Journal of Clinical Medicine
56. Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein
    Júlia Teixeira de Castro, Patrick Orestes de Azevedo, Marcílio Jorge Fumagalli, Natália Satchiko Hojo-Souza, Natália Salazar, Gregório Guilherme Almeida, Livia I. Oliveira, Lídia Faustino, Lis Ribeiro do Valle Antonelli, Tomas G. Marçal et al. · 2022 · Nature Communications
57. Proteomic analysis identifies a signature of disease severity in the plasma of COVID-19 pneumonia patients associated to neutrophil, platelet and complement activation
    Fabiola Ciccosanti, Manuela Antonioli, Alessandra Sacchi, Stefania Notari, Anna Farina, Alessia Beccacece, Marisa Fusto, Alessandra Vergori, Gianpiero D’Offizi, Fabrizio Taglietti et al. · 2022 · Clinical Proteomics
58. Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection
    Saeid Najafi Fard, Alessandra Aiello, Assunta Navarra, Gilda Cuzzi, Valentina Vanini, Giovanni Battista Migliori, Gina Gualano, Carlotta Cerva, Alba Grifoni, Alessandro Sette et al. · 2023 · International Journal of Infectious Diseases
59. SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial
    Αναστασία Παπαδοπούλου, George Karavalakis, Efthymia Papadopoulou, Aliki Xochelli, Zoi Bousiou, Anastasios Vogiatzoglou, Penelope Georgia Papayanni, Aphrodite Georgakopoulou, Maria Giannaki, Fani Stavridou et al. · 2023 · Nature Medicine
60. Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine
    Chiara Agrati, Concetta Castilletti, Delia Goletti, Alessandra Sacchi, Veronica Bordoni, Davide Mariotti, Stefania Notari, Giulia Matusali, Silvia Meschi, Linda Petrone et al. · 2022 · Scientific Reports
61. COVID-19 and the Immune Response: A Multi-Phasic Approach to the Treatment of COVID-19
    Tzuriel Sapir, Zaelig Averch, Brian Lerman, Abraham Bodzin, Yeshaya Fishman, Radhashree Maitra · 2022 · International Journal of Molecular Sciences
62. The intersection of COVID-19 and autoimmunity: What is our current understanding?
    Nicole Winchester, Cassandra M. Calabrese, Leonard H. Calabrese · 2021 · Pathogens and Immunity
63. The mutational landscape of SARS-CoV-2 variants diversifies T cell targets in an HLA-supertype-dependent manner
    David J. Hamelin, Dominique Fournelle, Jean‐Christophe Grenier, Jana Schockaert, Kevin A. Kovalchik, Peter Kubiniok, Fatima Mostefai, Jérôme D. Duquette, Frederic Saab, Isabelle Sirois et al. · 2021 · Cell Systems
64. Humoral and T-cell responses to SARS-CoV-2 vaccination in multiple sclerosis patients treated with ocrelizumab
    J.D. Katz, Andrew J. Bouley, R.M. Jungquist, E.A. Douglas, I.L. O'Shea, E.S. Lathi · 2021 · Multiple Sclerosis and Related Disorders
65. Asymptomatic and pre-symptomatic infection in Coronavirus Disease 2019 pandemic
    Yutong Wang, Ke Zheng, Wenjing Gao, Jun Lv, Canqing Yu, Lan Wang, Zijun Wang, Bo Wang, Chunxiao Liao, Liming Li · 2022 · Medical Review
66. Retinol Depletion in COVID-19
    Aziz Rodan Sarohan, Hakan Akelma, Eşref Araç, Özgür Aslan, Osman Çen · 2022 · Clinical Nutrition Open Science
67. Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles
    Aniuska Becerra‐Artiles, J. Mauricio Calvo‐Calle, Mary Dawn T. Co, Padma Pandurang Nanaware, John Cruz, Grant C. Weaver, Liying Lu, Catherine Suzanne Forconi, Robert W. Finberg, Ann Marie Moormann et al. · 2022 · Cell Reports
68. Spike-antibody responses to ChAdOx1 and BNT162b2 vaccines by demographic and clinical factors (Virus Watch study)
    Madhumita Shrotri, Ellen Fragaszy, Cyril Geismar, Vincent Grigori Nguyen, Sarah Beale, Isobel Braithwaite, Thomas Byrne, Wing Lam Erica Fong, Jana Kovar, Annalan M D Navaratnam et al. · 2021 · medRxiv
69. Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic
    Simeng Lin, Louis Ho Shing Lau, Neil Chanchlani, Nicholas Alexander Kennedy, Siew C. Ng · 2022 · Gut
70. Divergent adaptive immune responses define two types of long COVID
    Jérôme Kervevan, Isabelle Staropoli, Dorsaf Slama, Raphaël Jeger‐Madiot, Françoise Donnadieu, Delphine Planas, M P Pietri, Wiem Loghmari-Bouchneb, Motolete Alaba Tanah, Rémy Robinot et al. · 2023 · Frontiers in Immunology
71. Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2
    N. Taefehshokr, Sina Taefehshokr, B. Heit · 2020 · Pathogens
72. Host Genetics at the Intersection of Autoimmunity and COVID-19: A Potential Key for Heterogeneous COVID-19 Severity
    Tugce Karaderi, Halin Bareke, İmge Kunter, Adil Şeytanoğlu, Ilgın Çağnan, Deniz Balcı, Burc Barin, Mevhibe Hocaoğlu, Nilüfer Rahmioğlu, Esra Asilmaz et al. · 2020 · Frontiers in Immunology
73. The Magnitude and Functionality of SARS-CoV-2 Reactive Cellular and Humoral Immunity in Transplant Population Is Similar to the General Population Despite Immunosuppression
    Constantin J. Thieme, Moritz Anft, Krystallenia Paniskaki, Arturo Blazquez‐Navarro, Adrian Atilla Nicolas Doevelaar, Felix Sebastian Seibert, Bodo Hoelzer, Margarethe Konik, Toni Luise Meister, Stephanie Pfaender et al. · 2021 · Transplantation
74. Correlates of Neutralization against SARS-CoV-2 Variants of Concern by Early Pandemic Sera
    Samuel J. Vidal, Ai-ris Yonekura Collier, Jingyou Yu, Katherine McMahan, Lisa H. Tostanoski, John D. Ventura, Malika Aïd, Lauren E. Peter, Catherine Jacob-Dolan, Tochi Anioke et al. · 2021 · Journal of Virology
75. Machine learning identifies molecular regulators and therapeutics for targeting SARS‐CoV2‐induced cytokine release
    Marina Chan, Siddharth Vijay, John P. McNevin, M. Juliana McElrath, Eric C. Holland, Taranjit S. Gujral · 2021 · Molecular Systems Biology
76. Binding of phosphatidylserine‐positive microparticles by PBMCs classifies disease severity in COVID‐19 patients
    Lisa Rausch, Konstantin Lutz, Martina Schifferer, Elena Winheim, Rudi Gruber, Elina F. Oesterhaus, Linus Rinke, Johannes C. Hellmuth, Clemens Scherer, Maximilian Muenchhoff et al. · 2021 · Journal of Extracellular Vesicles
77. Phosphate-mediated coanchoring of RBD immunogens and molecular adjuvants to alum potentiates humoral immunity against SARS-CoV-2
    Kristen A. Rodrigues, Sergio A. Rodriguez-Aponte, N. C. Dalvie, J. Lee, Wuhbet D. Abraham, D. Carnathan, Luis E Jimenez, Julia T. Ngo, Jason Y. H. Chang, Zeli Zhang et al. · 2021 · Science Advances
78. Cellular Immunity—The Key to Long-Term Protection in Individuals Recovered from SARS-CoV-2 and after Vaccination
    Dragan Primorac, Petar Brlek, Vid Matišić, Vilim Molnar, Kristijan Vrdoljak, Renata Zadro, Marijo Parčina · 2022 · Vaccines
79. Rituximab‐treated patients with lymphoma develop strong CD8 T‐cell responses following COVID ‐19 vaccination
    Jon Riise, Saskia Meyer, Isaac Blaas, Adity Chopra, Trung The Tran, Marina Delić-Šarac, Malu Lian Hestdalen, Ellen Elisabeth Brodin, Even Holth Rustad, Ke‐Zheng Dai et al. · 2022 · British Journal of Haematology
80. The role of antigen-presenting cells in the pathogenesis of COVID-19
    Rana Farzi, Parisa Shiri Aghbash, Narges Eslami, Arezou Azadi, Ali Shamekh, Nima Hemmat, Taher Entezari‐Maleki, Hossein Bannazadeh Baghi · 2022 · Pathology - Research and Practice
81. Single cell sequencing analysis identifies genetics-modulated ORMDL3+ cholangiocytes having higher metabolic effects on primary biliary cholangitis
    Bingyu Xiang, Chunyu Deng, Fei Qiu, Jingjing Li, Shanshan Li, Huifang Zhang, Xiuli Lin, Yukuan Huang, Yijun Zhou, Jianzhong Su et al. · 2021 · Journal of Nanobiotechnology
82. Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4+ T cell recognition
    Emily X. C. Tye, Elizabeth Jinks, Tracey A. Haigh, Baksho Kaul, Prashant Patel, Helen Parry, Maddy L. Newby, Max Crispin, Nayandeep Kaur, Paul A. H. Moss et al. · 2022 · Nature Immunology
83. Vaccine‐breakthrough infection by the SARS‐CoV‐2 omicron variant elicits broadly cross‐reactive immune responses
    Runhong Zhou, Kelvin Kai‐Wang To, Qiaoli Peng, Jacky Man‐Chun Chan, Haode Huang, Dawei Yang, Bosco Hoi Shiu Lam, Vivien Wai‐Man Chuang, Jian‐Piao Cai, Na Liu et al. · 2022 · Clinical and Translational Medicine
84. The Immune Response to SARS-CoV-2 and Variants of Concern
    Elham Torbati, Kurt L. Krause, James E. Ussher · 2021 · Viruses
85. Neutralizing Antibodies and Cellular Immune Responses Against SARS-CoV-2 Sustained One and a Half Years After Natural Infection
    Lina Yan, Panpan Liu, Xu-gui Li, Shi-jing Zhou, Hao Li, Zhi-yin Wang, Feng Shen, Bichao Lu, Yu Long, Xiao Xiao et al. · 2022 · Frontiers in Microbiology
86. Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T cells in prepandemic and COVID-19 convalescent individuals
    Alexandra M. Johansson, Uma Malhotra, Yeseul G. Kim, Rebecca Gomez, Maxwell P. Krist, Anna Wald, David M. Koelle, William W. Kwok · 2021 · PLoS Pathogens
87. Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort
    Dominik Menges, Kyra D. Zens, Tala Ballouz, Nicole Caduff, Daniel Llanas-Cornejo, Hélène Eloise Aschmann, Anja Domenghino, Céline Pellaton, Matthieu Perreau, Craig W. Fenwick et al. · 2022 · Nature Communications
88. The Importance of Measuring SARS-CoV-2-Specific T-Cell Responses in an Ongoing Pandemic
    Linda Petrone, Alessandro Sette, Rory D. de Vries, Delia Goletti · 2023 · Pathogens
89. Features of developing SARS-CoV-2 nucleocapsid protein population-based seroprevalence during the first wave of the COVID-19 epidemic in the Russian Federation
    Anna Yu. Popova, Elena E. Andreeva, Elena A. Babura, С. В. Балахонов, Natalia S. Bashketova, M.V. Bulanov, N. N. Valeullina, D.V. Goryaev, Детковская Татьяна Николаевна, Elena B. Ezhlova et al. · 2021 · Russian Journal of Infection and Immunity
90. Prior COVID-19 protects against reinfection, even in the absence of detectable antibodies
    Aodhán Seán Breathnach, Christopher James Arthur Duncan, Kate El Bouzidi, Aidan T. Hanrath, Brendan A. I. Payne, Paul Anthony Randell, Maximillian S. Habibi, Peter Andrew Riley, Tim Planche, John Busby et al. · 2021 · Journal of Infection
91. MiRNA Profiling in Plasma and Placenta of SARS-CoV-2-Infected Pregnant Women
    I. Saulle, M. Garziano, C. Fenizia, G. Cappelletti, F. Parisi, M. Clerici, I. Cetin, V. Savasi, M. Biasin · 2021 · Cells
92. SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic
    Anna Yurievna Popova, В. С. Смирнов, Elena E. Andreeva, Elena A. Babura, С. В. Балахонов, Natalia S. Bashketova, Бугоркова Светлана Александровна, M.V. Bulanov, N. N. Valeullina, В. В. Ветров et al. · 2021 · Viruses
93. Favorable vaccine-induced SARS-CoV-2–specific T cell response profile in patients undergoing immune-modifying therapies
    Martin Qui, Nina Le Bert, Webber Pak Wo Chan, Malcolm Teck Kiang Tan, Shou Kit Hang, Smrithi Hariharaputran, Jean Xiang Ying Sim, Jenny Guek Hong Low, Weiling Ng, Wei Yee Wan et al. · 2022 · Journal of Clinical Investigation
94. Frailty impacts immune responses to Moderna COVID-19 mRNA vaccine in older adults
    Charles Semelka, Michael DeWitt, Maria W. Blevins, Beth C. Holbrook, John W. Sanders, Martha A. Alexander‐Miller · 2023 · Immunity & Ageing
95. Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunity
    Alexander Muik, Bonny Gaby Lui, Jasmin Quandt, Huitian Diao, Yunguan Fu, Maren Bacher, Jessica Gordon, Aras Toker, Jessica Grosser, Orkun Ozhelvaci et al. · 2023 · Cell Reports
96. mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognition
    Röltgen, Katharina, Nielsen, Sandra C. A., Arunachalam, Prabhu S., Yang, Fan, Hoh, Ramona A., Wirz, Oliver F., Lee, Alexandra S., Gao, Fei, Mallajosyula, Vamsee, Li, Chunfeng et al. · 2021
97. Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 Infections
    Allison E. Kennedy, Laura E. Cook, Jessica A. Breznik, Braeden Cowbrough, Jessica G. Wallace, Angela Huynh, James W. Smith, Kiho Son, Hannah D. Stacey, Jann Catherine Ang et al. · 2021 · Viruses
98. Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients
    Frank Bidar, Sarah Hamada, Morgane Gossez, Rémy Coudereau, Jonathan Lopez, Marie-Angélique Cazalis, Claire Tardiveau, Karen Brengel‐Pesce, Marine Mommert, Marielle Buisson et al. · 2022 · Annals of Intensive Care
99. CD8+ T Cells in SARS-CoV-2 Induced Disease and Cancer—Clinical Perspectives
    Keywan Mortezaee, Jamal Majidpoor · 2022 · Frontiers in Immunology
100. Spatially distributed infection increases viral load in a computational model of SARS-CoV-2 lung infection
     Melanie E. Moses, Steven A. Hofmeyr, Judy L. Cannon, Akil Andrews, Rebekah Gridley, Monica Hinga, Kirtus G. Leyba, Abigail Pribisova, Vanessa Surjadidjaja, Humayra Tasnim et al. · 2021 · PLoS Computational Biology